​

Funding Round

Series B - REGiMMUNE

Series B - REGiMMUNE

Investment Firm

Overview

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

Announced Date

Feb 01, 2008

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

NIF SMBC Ventures

NIF SMBC Ventures

NIF SMBC Ventures is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

8

Investor Name
Participant InvestorResona Capital
Participant InvestorNIF SMBC Ventures
Participant InvestorCSK Venture Capital
Participant InvestorYasuda Enterprise Development
Participant InvestorJapan Asia Investment

Round Details and Background

REGiMMUNE raised $6000000 on 2008-02-01 in Series B

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 14, 2014
Series D - REGiMMUNE
9-9.2M
Aug 15, 2006
Seed Round - REGiMMUNE
3-1.6M
Feb 21, 2007
Series A - REGiMMUNE
7-4.2M
Feb 01, 2008
Series B - REGiMMUNE
9-6.0M

Recent Activity

There is no recent news or activity for this profile.